Skip to content
百迈客生物 logo — 基因科技,改变世界——为世界创造新的可能!

百迈客生物

基因科技,改变世界——为世界创造新的可能!

Founded 2009 China China 85 employees Private Equity Total: $110.00M Biotechnology, Health Care

General Information

Company Name 百迈客生物
Founded Year 2009
Location China China
Employees 85
Industries Biotechnology, Health Care
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with 百迈客生物. To contact 百迈客生物, visit biomarker.com.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 百迈客生物 compare?

A PDF of 百迈客生物 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 百迈客生物 soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 百迈客生物

Biomarker Technologies is a Beijing-based startup that has been pioneering comprehensive genomic services since its establishment in 2009. The company boasts a team of over 500 experts who are dedicated to advancing the fields of biotechnology and health care. This highly-qualified team consists of technical staff, senior engineers, bioinformaticians, and experts proficient in various fields such as biotechnology, agriculture, medicine, and computing. The company's commitment to innovation and expertise has attracted investments, with a Private Equity Round investment made by Renhe Capital on 10 January 2016. Biomarker Technologies' focus on genomic services and its substantial R&D capabilities make it a noteworthy player in the fast-evolving biotechnology and health care industries.

Business keywords: Genomic Services, Medical Technology, R&D, Bioinformatics, Agriculture, Beijing, China, Science, Technology, Computing, Biomedical, Research, Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Renhe Capital
10 Jan 2016
Series B CNY100.00M 3
CD Capital, Renhe Capital +1
12 Jun 2015
Series A CNY10.00M 1
CASH Capital
24 Sep 2013

百迈客生物 Alternatives & Competitors

View All Alternatives
百迈客生物 vs

Employing cutting-edge science and technology to deliver breakthrough therapeutics.

Series A
15 employees
AI, Biotechnology
百迈客生物 vs

Empowering life science and medical research through advanced genetic testing medical devices and in...

Series C
17 employees
Biotechnology, Health Care
百迈客生物 vs
Wellcome Trust
Wellcome Trust United Kingdom

Wellcome supports research to transform health. We’re taking on climate change, infectious disease a...

Debt Financing
1407 employees
Biotechnology, Health Care

FAQ About 百迈客生物

基因科技,改变世界——为世界创造新的可能!
百迈客生物 was founded in 2009.
百迈客生物 is headquartered in China.
百迈客生物 operates in Biotechnology and Health Care. Its work centres on Genomic Services, Medical Technology, R&D and Bioinformatics.
百迈客生物 has approximately 85 employees.
百迈客生物 has completed 3 funding rounds, raising a total of $110.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to 百迈客生物 include Apeiron Therapeutics, 杭州联川生物技术股份有限公司, Wellcome Trust, Nanological, Sinogen Biopharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
百迈客生物 and Apeiron Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 百迈客生物, https://bouncewatch.com/company/biomarker-technologies, updated 15 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout